MARKSANS.BO
Price:
$183.95
Market Cap:
$83.37B
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Industry
Drug Manufacturers - General
IPO Date
Stock Exchange
BSE
Ticker
MARKSANS.BO
According to Marksans Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 81.87B. This represents a change of -22.85% compared to the average of 106.12B of the last 4 quarters.
The mean historical Enterprise Value of Marksans Pharma Limited over the last ten years is 30.10B. The current 81.87B Enterprise Value has changed 27.10% with respect to the historical average. Over the past ten years (40 quarters), MARKSANS.BO's Enterprise Value was at its highest in in the December 2024 quarter at 134.28B. The Enterprise Value was at its lowest in in the March 2020 quarter at 5.19B.
Average
30.10B
Median
19.07B
Minimum
5.05B
Maximum
98.83B
Discovering the peaks and valleys of Marksans Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 269.24%
Maximum Annual Enterprise Value = 98.83B
Minimum Annual Increase = -55.25%
Minimum Annual Enterprise Value = 5.05B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 98.83B | 41.12% |
| 2024 | 70.03B | 162.80% |
| 2023 | 26.65B | 63.81% |
| 2022 | 16.27B | -12.83% |
| 2021 | 18.66B | 269.24% |
| 2020 | 5.05B | -55.25% |
| 2019 | 11.30B | -22.73% |
| 2018 | 14.62B | -27.44% |
| 2017 | 20.14B | 3.40% |
| 2016 | 19.48B | -19.84% |
The current Enterprise Value of Marksans Pharma Limited (MARKSANS.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
65.17B
5-year avg
46.09B
10-year avg
30.10B
Marksans Pharma Limited’s Enterprise Value is less than Strides Pharma Science Limited (98.18B), less than Strides Pharma Science Limited (98.18B), greater than Aarti Pharmalabs Limited (65.41B), greater than Aarti Pharmalabs Limited (65.41B), less than Sanofi India Limited (96.99B), less than Sanofi India Limited (96.99B), greater than FDC Limited (67.26B), greater than FDC Limited (67.26B), greater than Yatharth Hospital & Trauma Care Services Limited (66.19B), greater than Yatharth Hospital & Trauma Care Services Limited (66.19B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 98.18B | $80.99B | |
| 98.18B | $81.17B | |
| 65.41B | $65.45B | |
| 65.41B | $65.41B | |
| 96.99B | $99.82B | |
| 96.99B | $99.73B | |
| 67.26B | $67.41B | |
| 67.26B | $67.51B | |
| 66.19B | $66.19B | |
| 66.19B | $66.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marksans Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marksans Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Marksans Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?
What is the 3-year average Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?
What is the 5-year average Enterprise Value for Marksans Pharma Limited (MARKSANS.BO)?
How does the current Enterprise Value for Marksans Pharma Limited (MARKSANS.BO) compare to its historical average?